BD Diagnostics Announces Agreement with BioReference Laboratories for BD Viper Robotic Instrumentation and Molecular Testing

23-Jun-2006

BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced the signing of an agreement with BioReference Laboratories of Elmwood Park, NJ (BRLI) for BD to supply BRLI with instrumentation and reagents for testing and diagnosis of sexually transmitted infections (STI).

Under this agreement testing for Chlamydia trachomatis and Neisseria gonorrhoeae will be run on the SCARA robotic automation platform of the BD Viper(TM) System. BD will be the primary supplier to BioReference for testing of these two infectious diseases.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances